Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Net Margin (2020 - 2026)

RxSight filings provide 6 years of Net Margin readings, the most recent being 28.07% for Q4 2025.

  • On a quarterly basis, Net Margin fell 8145.0% to 28.07% in Q4 2025 year-over-year; TTM through Dec 2025 was 28.96%, a 2892.0% decrease, with the full-year FY2025 number at 28.96%, down 2892.0% from a year prior.
  • Net Margin hit 28.07% in Q4 2025 for RxSight, up from 32.35% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 53.38% in Q4 2024 to a low of 219.03% in Q3 2021.
  • Median Net Margin over the past 5 years was 45.48% (2023), compared with a mean of 76.77%.
  • The widest YoY moves for Net Margin: up 62745bps in 2021, down -36052bps in 2021.
  • RxSight's Net Margin stood at 186.73% in 2021, then surged by 48bps to 97.03% in 2022, then skyrocketed by 67bps to 32.12% in 2023, then soared by 266bps to 53.38% in 2024, then plummeted by -153bps to 28.07% in 2025.
  • The last three reported values for Net Margin were 28.07% (Q4 2025), 32.35% (Q3 2025), and 35.04% (Q2 2025) per Business Quant data.